PolicyBytes

If a president’s going to have a legacy, constantly being associated with tax cuts is a pretty good one.

Real health care reform is happening, not in Congress or the Supreme Court, but in the eHealth explosion.

Had the health insurers stood up for free market principles and defended long-held actuarial principles for underwriting risk, the country might have avoided the ObamaCare nightmare.

While we all may agree that certain people are rich, determining where to draw the line-and what should be included in the calculation-is both difficult and arbitrary.

Counterfeit drugs are here and will only grow unless Congress and the FDA devise a better way to monitor prescription drugs from inception to ingestion.

Several Republicans reportedly want to retain certain provisions in ObamaCare, not because those provisions are good policy, but because they’re popular.

For the third time, the chief actuary has released an alternative (read: realistic) scenario for Medicare’s future budget. Although unprecedented, somebody has to tell the truth.

It’s bad enough that politicians think they can use taxpayer dollars to buy themselves votes. How much worse will it be if those politicians come to conclude they can force private sector companies to buy votes for them?

It's time to focus on one of the U.S.'s trade success stories: agriculture, and specifically genetically modified (GM) seeds.

There are precious few federal agencies that are able to respond to issues and challenges as fast as they should. Fortunately, there’s one that is.